Vector BioPharma
Vector BioPharma's cutting-edge gene precision delivery technology will transform the safety, efficacy, and specificity of biologics.
Vector BioPharma is active in the biotechnology, life science space based in Europe, Middle East, and Africa (EMEA), founded in 2021.
Its activity falls under biotechnology, life science; the profile below is assembled from public directory data.
The company is recorded as being based in Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_A stage of development.
Recorded headcount: c_00011_00050 employees.
Total disclosed funding stands at about $30M.
| Sector | Biotechnology, Life Science |
|---|---|
| Headquarters | Europe, Middle East, and Africa (EMEA) |
| Founded | 2021 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $30,000,000 |
Website: www.vectorbiopharma.com
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account